MiMedx
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 2008-02-28
- Employees
- 895
- Market Cap
- -
- Website
- http://www.mimedx.com
- Introduction
MiMedx Group, Inc. is a therapeutic biologics company, which engages in the design, manufacture, and marketing of products, and tissue processing services. It serves the wound care, burn, surgical, orthopedic, spine, sports medicine, ophthalmic, and dental sectors of healthcare. Its biomaterial platform technologies include AmnioFix and EpiFix, a tissue allografts derived from amnion and chorion layers of human placental membrane, EpiCord and AmnioCord, a tissue allografts derived from umbilical cord tissue, and AmnioFill, a placental connective tissue matrix derived from the placental disc and other placental tissue. The company was founded on July 30, 1985 and is headquartered in Marietta, GA.
Modified Platform Trial Evaluating PpLHACM and SOC Versus SOC Alone in the Treatment of Nonhealing DFUs
- Conditions
- Diabetic Foot UlcerDiabetic FootFoot Ulcer Due to Type 2 Diabetes MellitusFoot Ulcer, DiabeticFoot Ulcer
- Interventions
- Other: Standard of CareOther: EPIEFFECTOther: EPIXPRESS
- First Posted Date
- 2024-09-19
- Last Posted Date
- 2024-09-19
- Lead Sponsor
- MiMedx Group, Inc.
- Target Recruit Count
- 170
- Registration Number
- NCT06600724
- Locations
- 🇺🇸
SerenaGroup - Monroeville, Monroeville, Pennsylvania, United States
Post-Marketing Surveillance of Dehydrated Human Amnion/Chorion Membrane (DHACM) in Non-Ischemic Chronic Wounds
- Conditions
- Venous Leg UlcerDiabetic Foot Ulcer
- Interventions
- Device: EPIFIX
- First Posted Date
- 2024-02-01
- Last Posted Date
- 2024-02-01
- Lead Sponsor
- MiMedx Group, Inc.
- Target Recruit Count
- 75
- Registration Number
- NCT06236750
- Locations
- 🇯🇵
Kyorin University Hospital, Mitaka-shi, Tokyo, Japan
🇯🇵Kobe University Hospital, Kobe-shi, Hyogo, Japan
🇯🇵Tokyo Medical University Hospital, Shinjuku-Ku, Tokyo, Japan
Phase 2B Micronized DHACM vs. Saline in the Treatment of Knee Osteoarthritis
- Conditions
- Knee Osteoarthritis
- Interventions
- Biological: Micronized DHACM 40 mgBiological: Micronized DHACM 100 mgDrug: Saline
- First Posted Date
- 2023-04-04
- Last Posted Date
- 2024-01-17
- Lead Sponsor
- MiMedx Group, Inc.
- Target Recruit Count
- 43
- Registration Number
- NCT05796765
- Locations
- 🇺🇸
Horizon Clinical Research, La Mesa, California, United States
🇺🇸Rochester Clinical Research, Inc., Rochester, New York, United States
🇺🇸Healthcare Research Network, Hazelwood, Missouri, United States
A Single Center, Prospective, Case Series of the Treatment of Pressure Ulcers and Decubitus Ulcers.
- Conditions
- Pressure Ulcer
- Interventions
- Procedure: dHACM
- First Posted Date
- 2018-05-18
- Last Posted Date
- 2020-11-13
- Lead Sponsor
- MiMedx Group, Inc.
- Target Recruit Count
- 20
- Registration Number
- NCT03529578
- Locations
- 🇺🇸
Infectious Disease Specialists of Atlanta, PC, Decatur, Georgia, United States
Micronized dHACM vs. Saline in the Treatment of Osteoarthritis of the Knee
- Conditions
- Knee Osteoarthritis
- Interventions
- Drug: SalineBiological: Micronized dHACM
- First Posted Date
- 2018-04-02
- Last Posted Date
- 2023-12-11
- Lead Sponsor
- MiMedx Group, Inc.
- Target Recruit Count
- 447
- Registration Number
- NCT03485157
- Locations
- 🇺🇸
Fiel Family and Sports Medicine, Tempe, Arizona, United States
🇺🇸UConn Health, Farmington, Connecticut, United States
🇺🇸Horizon Clinical Research, La Mesa, California, United States
Use of Human Dehydrated Amnion Chorion Allograft in Laryngectomy/Pharyngectomy
- Conditions
- Pharynx CancerPharyngocutaneous FistulaLarynx Cancer
- Interventions
- Biological: Dehydrated human amnion/chorion membrane
- First Posted Date
- 2018-03-27
- Last Posted Date
- 2020-11-13
- Lead Sponsor
- MiMedx Group, Inc.
- Target Recruit Count
- 8
- Registration Number
- NCT03479463
- Locations
- 🇺🇸
Mount Sinai Hospital, New York, New York, United States
Use of Human Dehydrated Amnion Chorion Allograft in Closed Hemorroidectomy
- Conditions
- External Hemorrhoid ThrombosedExternal Hemorrhoid
- Interventions
- Other: Human dehydrated amnion chorion allograft
- First Posted Date
- 2018-03-27
- Last Posted Date
- 2019-12-18
- Lead Sponsor
- MiMedx Group, Inc.
- Target Recruit Count
- 11
- Registration Number
- NCT03479489
- Locations
- 🇺🇸
Boulder Valley Surgical Associates, Boulder, Colorado, United States
Micronized dHACM Injectable for the Treatment of Achille Tendonitis
- Conditions
- Tendonitis;Achilles
- Interventions
- Biological: Micronized DHACMDrug: Saline Injection
- First Posted Date
- 2018-01-29
- Last Posted Date
- 2022-05-19
- Lead Sponsor
- MiMedx Group, Inc.
- Target Recruit Count
- 146
- Registration Number
- NCT03414255
- Locations
- 🇺🇸
Coastal Podiatry, Inc., Virginia Beach, Virginia, United States
🇺🇸Doctors Research Network, Miami, Florida, United States
🇺🇸Futuro Clinical Trials, McAllen, Texas, United States
Micronized dHACM Injectable for the Treatment of Plantar Fasciitis
- Conditions
- Fasciitis, Plantar
- Interventions
- Other: Micronized dHACMDrug: Saline Injection
- First Posted Date
- 2018-01-29
- Last Posted Date
- 2022-05-19
- Lead Sponsor
- MiMedx Group, Inc.
- Target Recruit Count
- 208
- Registration Number
- NCT03414268
- Locations
- 🇺🇸
ILD Research Center, Carlsbad, California, United States
🇺🇸Horizon Clinical Research, La Mesa, California, United States
🇺🇸Five Cities Foot Clinic, Pismo Beach, California, United States
Use of Human Dehydrated Amnion/Chorion (DHACM) Allograft in Partial Nephrectomy
- Conditions
- Partial NephrectomyKidney CancerRenal Function Aggravated
- Interventions
- Other: Dehydrated human amnion/chorion membraneOther: Standard of Care
- First Posted Date
- 2017-10-26
- Last Posted Date
- 2020-11-13
- Lead Sponsor
- MiMedx Group, Inc.
- Target Recruit Count
- 61
- Registration Number
- NCT03323021
- Locations
- 🇺🇸
The Mount Sinai Hospital, New York, New York, United States